Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the
development or recurrence of cancer. Celecoxib may be effective in preventing cancer in
patients with Barrett's esophagus.
PURPOSE: Randomized phase II trial to study the effectiveness of celecoxib in preventing
cancer in patients who have Barrett's esophagus.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins